Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	4338-47-0
Formula :	C₁₅H₁₇N₅O₅
M.W :	347.33
SMILES Code :	O[C@H]([C@@H]1O)[C@@H](O[C@@H]1CO)N2C=NC3=C2N=CN=C3NCC4=CC=CO4
Synonyms :	N6-Furfuryladenosine; NSC 120958
MDL No. :	MFCD00037987

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H315-H320-H335
Precautionary Statements:	P261-P280-P301+P312-P302+P352-P305+P351+P338

Primary mouse fibroblasts	50 μM	24 hours	Induced PINK1-dependent mitophagy	J Med Chem. 2023 Jun 8;66(11):7645-7656
Astrocytes	50 μM	24 hours	Inhibited valinomycin-induced ubiquitin phosphorylation	J Med Chem. 2023 Jun 8;66(11):7645-7656
Human monocyte THP-1 (M0 macrophages)	100 nm	48 hours	Activate ACE2 expression	Int J Biol Sci. 2020 Jun 27;16(13):2382-2391
Human gastric epithelial cell GES-1	100 nm	48 hours	Activate ACE2 expression	Int J Biol Sci. 2020 Jun 27;16(13):2382-2391
MitoQC-PMCs	0.3 - 5 µM	72 hours	To evaluate the effect of Kinetin riboside on mitophagy and mitochondrial fusion. Results showed that KR activated mitophagy and relaxed mitochondrial hyperfusion in a concentration-dependent manner.	Nat Commun. 2024 Feb 6;15(1):1124
MIO-M1 Müller cells	0.3 - 5 µM	72 hours	To evaluate the effect of Kinetin riboside on mitochondrial dynamics and function under diabetic conditions. Results showed that KR restored mitochondrial membrane potential, improved mitochondrial bioenergetics, and activated mitophagy.	Nat Commun. 2024 Feb 6;15(1):1124
HEK293 Flp-In TRex HEK293 cells	50 μM	3, 6, 12, 24, 48 hours	Time-dependent evaluation of PINK1 activation by KR ProTide 13, with the most significant activation observed at 24 hours.	J Med Chem. 2017 Apr 27;60(8):3518-3524
HEK293 Flp-In TRex HEK293 cells	50 μM	24 hours	To evaluate the activation of PINK1 by Kinetin riboside and its ProTides, results showed that KR and three ProTides (11, 13, 14) significantly activated PINK1 in the absence of CCCP, as evidenced by enhanced Parkin Ser65 phosphorylation.	J Med Chem. 2017 Apr 27;60(8):3518-3524
HeLa cells	50 μM	24 hours	Inhibited CCCP- and niclosamide-induced ubiquitin phosphorylation	J Med Chem. 2023 Jun 8;66(11):7645-7656
A172 cells	20, 40, 80 µM	6 hours	To evaluate the effect of KR on A172 cell apoptosis, results showed that KR induced apoptosis in a concentration-dependent manner.	Apoptosis. 2020 Dec;25(11-12):835-852
T47D cells	20, 40, 80 µM	6 hours	To evaluate the effect of KR on T47D cell apoptosis, results showed that KR induced apoptosis in a concentration-dependent manner.	Apoptosis. 2020 Dec;25(11-12):835-852
HepG2 cells	20, 40, 80 µM	6 hours	To evaluate the effect of KR on HepG2 cell proliferation, results showed that KR inhibited cell proliferation in a concentration- and time-dependent manner and induced apoptosis.	Apoptosis. 2020 Dec;25(11-12):835-852
Human dermal neonatal foreskin Hs27 fibroblasts	0.18 ± 0.01 μM	72 hours	To assess the antiproliferative activity of FAdo, results showed significant inhibition of cell proliferation at submicromolar concentrations.	Biochem Pharmacol. 2009 Apr 1;77(7):1125-38
Primary human epidermal keratinocytes	0.11 ± 0.03 μM	72 hours	To assess the antiproliferative activity of FAdo, results showed significant inhibition of cell proliferation at submicromolar concentrations.	Biochem Pharmacol. 2009 Apr 1;77(7):1125-38
HCT116 colon carcinoma cells	0.72 ± 0.02 μM	72 hours	To assess the antiproliferative activity of FAdo, results showed significant inhibition of cell proliferation at submicromolar concentrations.	Biochem Pharmacol. 2009 Apr 1;77(7):1125-38
HT29 colon carcinoma cells	3.00 ± 0.65 μM	72 hours	To assess the antiproliferative activity of FAdo, results showed significant inhibition of cell proliferation at micromolar concentrations.	Biochem Pharmacol. 2009 Apr 1;77(7):1125-38
LOX metastatic melanoma cells	0.16 ± 0.02 μM	72 hours	To assess the antiproliferative activity of FAdo, results showed significant inhibition of cell proliferation at submicromolar concentrations.	Biochem Pharmacol. 2009 Apr 1;77(7):1125-38
G361 Human melanoma cells	1.52 ± 0.52 μM	72 hours	To assess the antiproliferative activity of FAdo, results showed significant inhibition of cell proliferation at micromolar concentrations.	Biochem Pharmacol. 2009 Apr 1;77(7):1125-38
A375 melanoma cells	0.28 ± 0.01 μM	72 hours	To assess the antiproliferative activity of FAdo, results showed significant inhibition of cell proliferation at submicromolar concentrations.	Biochem Pharmacol. 2009 Apr 1;77(7):1125-38
MiaPaCa-2 pancreas carcinoma cells	0.27 ± 0.09 μM	72 hours	To assess the antiproliferative activity of FAdo, results showed significant inhibition of cell proliferation at submicromolar concentrations.	Biochem Pharmacol. 2009 Apr 1;77(7):1125-38
T98G cells	40, 80, 200 μM	24 hours	To evaluate the effects of KR and 7-deazaKR on proliferation and apoptosis in T98G cells. Results showed that KR and 7-deazaKR inhibited cell proliferation and induced apoptosis in a dose-dependent manner.	Antioxidants (Basel). 2021 Jun 12;10(6):950
Primary CD138+ myeloma cells	10 μM	16 hours	In 4 out of 5 primary myeloma cell samples, kinetin riboside significantly suppressed the major cyclin D protein expression, but had no effect in one plasma cell leukemia sample.	J Clin Invest. 2008 May;118(5):1750-64
U266 myeloma cells	10 μM	16 hours	Kinetin riboside significantly suppressed cyclin D1 protein expression but had no significant effect on cyclin D3.	J Clin Invest. 2008 May;118(5):1750-64
KMS11 myeloma cells	10 μM	16 hours	Kinetin riboside significantly suppressed cyclin D2 protein expression but had no significant effect on cyclin D3.	J Clin Invest. 2008 May;118(5):1750-64
H929 myeloma cells	10 μM	6 hours	Kinetin riboside significantly suppressed cyclin D1 and D2 protein expression within 6 hours, leading to cell cycle arrest at G0/G1 phase.	J Clin Invest. 2008 May;118(5):1750-64

Mice	Ins2Akita diabetic mouse model	Oral (via drinking water)	60 mg/L (equalling 90 mg/kg/day)	Three times per week for 2 weeks or from 4 to 8 months	To evaluate the neuroprotective effects of Kinetin riboside in the diabetic mouse retina. Results showed that KR restored mitochondrial turnover, improved retinal neurodegeneration, and protected retinal function regardless of glycaemic status.	Nat Commun. 2024 Feb 6;15(1):1124
Nude mice	MY5 and 8226 myeloma xenograft models	Intraperitoneal and subcutaneous injection	85 mg/kg/dose, 4-5 times daily	4-5 times daily, continuous treatment	Kinetin riboside significantly inhibited tumor growth in MY5 and 8226 myeloma xenograft models, with tumor regression observed at 5 times daily dosing.	J Clin Invest. 2008 May;118(5):1750-64
Mice	Intranasal vesicular stomatitis virus (VSV) infection model	Intravenous injection	50 mg/kg (for interferon production), 30 mg/kg (for antiviral protection)	Single injection	To study the effects of kinetin riboside and isopentenyladenosine on (polyrI)·(polyrC)-induced interferon production and antiviral protection. Results showed that these nucleoside analogs significantly reduced the interferon-inducing capacity and antiviral protection of (polyrI)·(polyrC).	J Clin Invest. 1970 Aug;49(8):1565-77

{[proInfo.proName]}

CAS No.: 4338-47-0

{[proInfo.proName]}

CAS No.: 4338-47-0

Alternative Products

Product Details of Kinetin riboside

Safety of Kinetin riboside

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

Bio Calculators
Preparing Stock Solutions		1mg	5mg	10mg
Preparing Stock Solutions	1 mM 5 mM 10 mM	2.88mL 0.58mL 0.29mL	14.40mL 2.88mL 1.44mL	28.79mL 5.76mL 2.88mL
Dissolving Methods	Animal experiment Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn: in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Protocol 1 Protocol 2

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed